Alpha-Stim AID
Commercial- Indications
- Anxiety, Insomnia, Depression
Company intelligence / Profile preview
Electromedical Products International has commercialized the Alpha-Stim line of non-invasive neuromodulation devices FDA-cleared for anxiety, insomnia, and pain. The company’s products are supported by over four decades of clinical research. Their next-generation pipeline includes advanced closed-loop brain stimulation technologies under development by their wholly-owned subsidiary Pulvinar Neuro. Devices are used globally in both clinical practice and research settings.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Electromedical Products International.